Leerink Partners Maintains Tenax Therapeutics(TENX.US) With Buy Rating, Raises Target Price to $20

Moomoo NewsMar 10 10:32 ET · Ratings

William Blair Maintains Tenax Therapeutics(TENX.US) With Buy Rating

Moomoo NewsMar 10 07:31 ET · Ratings

Express News | Tenax Therapeutics Inc : Leerink Partners Raises Target Price to $20 From $16

ReutersMar 10 07:22 ET

Promising Developments and Financial Backing Drive Buy Rating for Tenax Therapeutics

TipRanksMar 10 06:45 ET · Ratings

Roth MKM Reaffirms Their Buy Rating on Tenax Therapeutics (TENX)

TipRanksMar 6 08:19 ET · Ratings

Tenax Therapeutics Shares Are Trading Higher After Announcing the FDA Has Completed Its Review of the Company's Updated Phase 3 Plan for TNX-103.

BenzingaMar 5 09:18 ET